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Abstract: The incidence of a disease can be easily estimated from serial prevalence
data. However, diculties usually arise in the case of prevalence data measured only
once. This paper presents and assesses various methods for estimating the incidence of
a disease in the latter case. The focus is on how applicable the methods are to the
estimation of the incidence of the HIV-epidemic in some parts of Africa where data from
serial cross-sectional surveys are hard available.
1 Introduction
The prevalence of a disease is its relative frequency in a population. It therefore corres-
ponds to the probability of being aected by the disease. The incidence of a disease is the
proportion of new cases of disease within a determined period in the population. This
can be distinguished between cumulative incidence and the incidence rate or density. The
cumulative incidence is dened as the ratio of the number of aected people and the
population size within a time interval. It gives the probability of people falling ill during
such a time interval. The incidence rate, on the other hand, is the ratio of the number of
people falling ill and the average population at risk. It states the actual risk of catching
the disease (Kreienbrock and Schach [1995]; Chap. 2).
Whereas prevalence does not cover cured people and the deceased, incidence considers
all cases of the disease. Consequently, for the planning of clinical or epidemiological
studies, knowledge of the incidence of the disease of interest is essential, as well as the
number of persons required in a vaccine trial. It is well-known that the future development
of a disease can be predicted by means of incidence estimation. Also, the eects of
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measures taken against the disease can be statistically compared (Gregson et al. [1996];
Ades and Nokes [1993]; Podgor et al. [1983]; Heyward et al. [1994]).
The use of prevalence data as an estimator for the incidence is not appropriate in
many situations. This is because prevalence is a function of both incidence and duration
of disease. For example, the prevalence of a chronic disease might be very high even when
its incidence is low. It is important to note that constant prevalence data over time do
not usually give an indication of the development of the incidence (Saidel et al. [1996];
Leske et al. [1981]; Freeman and Hutchison [1980]).
Due to the high number of reported AIDS-cases in some parts of Africa and Asia,
it is of particular importance therefore to have reliable data about the spreading of the
HIV-infection. However, nancial and logistic restrictions often do not permit large and
well planned cohort studies from which HIV-incidence could be easily estimated. In the
case of cohort studies, the proportion of new infections in the given time intervals is
an estimator for the cumulative incidence. Instead of expensive cohort studies, low cost
cross-sectional studies are generally conducted. Cross-sectional studies are much easier
to conduct because they do not require personal information for the identication of the
study participants (Ades and Nokes [1993]; Brookmeyer et al. [1995]).
Available methods for estimating the incidence, such as backward calculation by means
of AIDS-prevalence data and mathematical models, have several drawbacks. Backward
calculation, for instance, cannot give a reliable estimation of the present HIV-incidence,
because the data used are not reected in present AIDS-prevalence data. The mathe-
matical models require detailed information on many parameters which are usually not
available (Saidel et al. [1996]; Brundage et al. [1990]; Brookmeyer and Quinn [1995]).
In order to estimate the incidence of a disease by means of prevalence studies in
which measurement is done only once, several approaches have been recently developed,
especially with respect to the HIV-epidemic. This paper presents an assessment of these
new approaches with a focus on their relevance to the AIDS-epidemic.
2 Incidence Estimation by Means of Prevalence Data
In this section several deterministic and stochastic approaches as well as data conditions
will be represented. Detailed descriptions of these methods can be found in the literature
cited in the text.
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The following notation will be used:
N Population size,
N
k
Population size during age interval k,
P Prevalence,
P
k
Prevalence during age interval k,
P(a) Prevalence at age a,
P
t
(a, a+r) Prevalence during age interval [a, a+r] at time t,
P
N
Absolute prevalence number,
I Cumulative incidence,
I
k
Cumulative incidence during age interval k,
I(a) Cumulative incidence at age a,
 Incidence rate,

k
Incidence rate during age interval k,
(a) Incidence rate at age a,

t
(a) Incidence rate at age a and time t,
R Net probability for developing disease,
R
k
Net probability for developing disease during age interval k,
q
k
Probability of dying during age interval k,
p
+
x,a
Probability of surviving HIV-related mortality until age a
after infection with HIV at age x,

+
a,a+r
Probability of surviving the age interval [a, a+r]
from HIV-related mortality.
There are two kinds of incidence estimation | the estimation of the cumulative inci-
dence and the estimation of the incidence rate. Cumulative incidence is also termed as
the crude probability for falling ill since it does not take in account the probability for
dying. The incidence rate, on the other hand, is termed as net risk of catching a disease
as it refers only to the healthy population.
If a constant incidence rate can be assumed for a time interval, then the periods until
falling ill are distributed exponentially. In case of short time intervals of length  and
a low incidence rate, cumulative incidence (I) and incidence rate () are interrelated as
follows (Kreienbrock and Schach [1995]; pp. 20):
I = 1  e
 
  : (1)
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2.1 Interrelation of Prevalence and Incidence
Prevalence, incidence and the duration of a disease in a steady-state population are in-
terrelated in such a way that any two of the three quantities may be used to obtain the
third (Freeman and Hutchison [1980]).
Steady-state assumptions are the following:
1. Incidence and the distribution of duration of illness within the population remain
constant over time; and
2. The total population of aected and unaected individuals, respectively, remains
constant over time.
Let D be the duration of the disease and E(D) the corresponding expectation value.
Then:
P
N
= P  N = I  E(D); (2)
and
P =
  E(D)
1 + E(D)
,
P
1  P
=   E(D): (3)
It follows that when the steady-state assumptions are fullled, cumulative incidence and
incidence rate can be calculated from prevalence data if the expectation value of the
duration of the disease is given. Given
^
P , an estimation for P, estimations for I and ,
^
I
and ^ respectively, can be obtained with the use of equations (2) and (3).
Equation (2) is exact if incidence and the distribution of duration of the disease remain
constant over time. The constant condition for both quantities must hold for as long as
the longest disease duration included in the distribution. This is because the number
of aected people can consist of all new cases within that time period. The incidence
rate can then be estimated by means of equation (3). This equation is exact when both
steady-state assumptions are met.
An application of the above interrelations of incidence and prevalence with regard
to the HIV-epidemic is provided by Brookmeyer and Quinn (1995). In the setting of a
cross-sectional study in India, more than 1900 people were tested for HIV. In addition,
seronegatives were tested for the p24 antigen. This antigen can be detected in HIV-
infected individuals already during the preantibody period. The expectation value of the
duration of the p24 antigen period before seroconversion is estimated by the collected
data, after which equation (2) is used for the estimation of the cumulative incidence. The
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calculation of condence intervals is based on the assumption that the number of p24
antigen prevalent individuals follows a Poisson distribution.
2.2 Incidence Estimation from Age-Specic Prevalence Data
In the following, approaches developed by Leske et al. (1981, 1986) for diseases which
do and do not aect mortality risk are presented. The approach of Elandt-Johnson and
Johnson (1980) is also presented. It is important to note that all approaches assume
disease to be irreversible.
2.2.1 Equal Mortality for Aected and Unaected Individuals
A deterministic approach is chosen in this case of equal mortality for aected and un-
aected individuals. It is assumed that disease incidence and population composition
(regarding risk factors for disease) remain constant over time (Leske et al. [1981]).
The starting point of the model is the total number of aected individuals at the
beginning of the age interval k+1. This number consists of all individuals who either
were already aected at the beginning of the age interval k or developed the disease
during the interval and, in both cases, who did not die during the age interval k:
N
k+1
P
k+1
= N
k
P
k
(1  q
k
) + I
k
(N
k
  N
k
P
k
)(1  q
k
): (4)
Using N
k+1
= N
k
(1  q
k
), the cumulative incidence can be calculated as follows:
I
k
=
P
k+1
  P
k
1  P
k
: (5)
Usually, the knowledge of the incidence rate 
k
is of higher interest since 
k
refers to the
risk of developing the disease in the presence of competing mortality (Ederer [1964]). It
is the ratio of the number of new cases and the average risk population in the k-th age
interval.
In the following equation, h
k
represents the proportion of new cases who die out of all
(theoretical) individuals who develop the disease and die during this age interval:

k
=
I
k
(N
k
  N
k
P
k
)(1  q
k
) + I
k
(N
k
  N
k
P
k
)q
k
h
k
(N
k
  N
k
P
k
)(1 
1
2
q
k
)
: (6)
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The denominator in (6) indicates that periods from the beginning of the age interval until
death are supposed to be distributed uniformly. The incidence rate reduces to:

k
=
I
k
h
1  q
k
(1  h
k
)
i
(1 
1
2
q
k
)
: (7)
The value of 
k
is equal to the cumulative incidence I
k
, if h
k
=
1
2
, which means that periods
until death and until developing the disease follow the same distribution. If disease-free
periods and survival periods are assumed to be exponentially distributed with dierent
parameters, then:

k
=
ln(1  I
k
)
ln(1  q
k
) + ln(1  I
k
)
1  (1  I
k
)(1  q
k
)
1 
1
2
q
k
: (8)
Using equation (5), in this case the incidence rate is calculated by means of the prevalence
and the probability of dying. The variance of the corresponding estimator is derived by
the delta method (Leske et al. [1981]).
Leske et al. (1981) and Podgor et al. (1983) have used the above equations to estimate
cumulative incidence and incidence rate in connection with the investigation of several
eye diseases in England and in the United States, respectively. In both studies there is
hardly any dierence between
^
I and ^ for the chosen age intervals, which is supposed to
be the case due to the low probability of dying.
2.2.2 Dierent Mortality for Aected and Unaected Individuals
Similar to section 2.2.1 the starting point for the case of dierent mortality for aected
and unaected individuals (q
0
k
and q
k
, respectively) is equation (4). In this case, however,
the total number of unaected individuals at the beginning of age interval k+1 is given
by:
N
k+1
  N
k+1
P
k+1
= (N
k
  N
k
P
k
)(1  I
k
)(1  q
k
): (9)
Independent exponential distributions are assumed for periods from the beginning of
the age interval k to: (a) death in the absence of disease; (b) occurrence of disease; and (c)
death in the presence of disease. The corresponding parameters are 
1
, 
2
, and 
3
. Given
this model, 
2
corresponds to the disease incidence rate 
k
(Podgor and Leske [1986]).
Transforming equations (4) and (9) results in the following:
1  P
k
1  P
k+1
P
k+1
e
 (
1
+
2
)
= P
k
e
 
3
+ (1  P
k
)(e
 
3
  e
 (
1
+
2
)
)

2

1
+ 
2
  
3
: (10)
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If 
1
and 
3
are known, 
2
can be estimated for age interval k using the estimates for P
k
and P
k+1
. Equation (10) is non-linear in 
2
, so it can be solved by standard methods
such as the Newton-Raphson algorithm. Estimates for the variance of
^

2
are derived by
the delta method.
If 
1
= 
3
, and using I
k
= 1  e
 
2
, equation (5) is obtained:
I
k
=
P
k+1
  P
k
1  P
k
;
as well as:

2
= 
k
=   ln
 
P
k+1
  P
k
1  P
k
!
: (11)
The cumulative incidence I
k
corresponds to the crude probability for developing the dis-
ease since it disregards mortality risk. If mortality risk is considered, the net probability
for developing the disease, R
k
, becomes:
R
k
=

2

1
+ 
2
(1  e
 (
1
+
2
)
): (12)
Applications of this method in the context of studies about eye diseases in England and
HIV in Burundi can be found in publications of Podgor and Leske (1986) and Saidel et al.
(1996), respectively.
2.2.3 Method of Elandt-Johnson and Johnson
For the case of equal mortality for aected and unaected individuals, Elandt-Johnson and
Johnson (1980) have developed a recursive formula for the calculation of the cumulative
incidence in each age interval k using prevalence data:
I
k+1
= 2(P
k+1
  P
k
)  I
k
; where I
0
= 2P
0
: (13)
This implies that prevalence is taken at the midpoint of each interval. Unlike the methods
of Leske et al. (1981), periods from the beginning of an age interval until occurrence of
disease are assumed to be distributed uniformly when using the Elandt-Johnson and
Johnson method. Also, neither an estimator for the variance of
^
I
k
, nor a formula for

k
is given. As above, the disease is supposed to be irreversible. Moreover, the disease
must not be an uncommon one, otherwise estimates for the cumulative incidence could
be negative.
Elandt-Johnson and Johnson have presented a similar method for the case of dierent
mortality of aected and unaected individuals, which requires data from life tables for
aected individuals. However, these data are hardly available.
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2.3 Methods of Gregson et al.
Gregson et al. (1996) present two dierent approaches for the estimation of the HIV-
incidence with the use of seroprevalence data. In both cases the incidence rate is modeled
as a continuous function of age. Age-specic incidence rates and HIV-related mortality
are required to remain constant over time.
Hence, cumulative incidence as a function of age is given as follows:
I(a) =
a
Z
0
(x)e
 
R
x
0
(y)dy
dx: (14)
2.3.1 Cumulative Incidence and Survival Method
The rst of the two approaches of Gregson et al. (1996) is the cumulative incidence and
survival method. Its objective is to interpret the prevalence at age a, P(a), as the cumu-
lative incidence up to age a, adjusted for mortality. This means that the proportion of
HIV-infected individuals with age a in the whole population is equivalent to the propor-
tion of individuals infected at age a-x, x > 0, who survived the following x years. Thus,
P(a) can be written as follows:
P(a) =
a
R
0
(x)e
 
R
x
0
(y)dy
p
+
x,a
dx
a
R
0
(x)e
 
R
x
0
(y)dy
p
+
x,a
dx + e
 
R
a
0
(y)dy
; (15)
where both (a) and p
+
x,a
must be specied. Gregson et al. (1996) suggest the following
age-specic pattern for the incidence rate:
(a) =  exp
 
 
(a  U)
2
(
U
2
)
2
!
I
[L;U ]
(a); ; ;  > 0; (16)
where L and U are the lower and upper age limits beyond which HIV-incidence is negli-
gible. High values of the parameters ,  and  tend to indicate high levels of incidence
rate, similar level of incidence rate across a broad range of ages, and an older peak age-at-
infection, respectively. The survival periods are assumed to follow a Weibull distribution
with parameters ' and M, where M is the median survival period.
Using the estimates for P(a) and the maximum likelihood method, ^;
^
; ^; '^;
^
M can
be calculated and hence ^(a). A variance estimation for the estimators of the parameters
is not given. Condence intervals are calculated by means of the log-likelihood ratio.
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A similar approach can be found in an article by Ades and Nokes (1993). The incidence
rate, (a,t), is modeled as a function of both age and time. Two dierent specications
of (a,t) are given. In order to separate the dependence on age from the dependence on
time, serial prevalence studies are required.
2.3.2 Constant Prevalence Method
This method is similar to the one by Podgor and Leske (1986) in case of dierent mortal-
ity for aected and unaected individuals. The cumulative incidence in the time interval
[t-r, t] for the age group [a-r, a] is the net increase in prevalence within this cohort over
the time interval, after adjusting for deaths to infected and uninfected individuals. How-
ever, whereas Podgor and Leske (1986) assume exponentially distributed survival periods
(see 2.2.2), Gregson et al. (1996) estimate the mortality for each time interval.
After various transformations, the estimator for the incidence as function of age at
time t results in:
^
t
(a) =
^
P
t
(a, a+r)
h
1 
^
P
t
(a-r, a)
i
+
^
P
t
(a-r, a)
h
^
P
t
(a, a+r)  1
i

+
a-r/2,a+r/2
h
1 
^
P
t
(a-r, a)
i h
1 
^
P
t
(a, a+r)
i

+
a,a+r/2
+
^
P
t
(a, a+r)
: (17)
It is assumed that infection with HIV occurs at the midpoints of the age and time intervals.
The survival probability 
+
is given as follows:

+
a-r/2,a+r/2
=
a
R
0
(x)e
 
R
x
0
(y)dy
p
+
x,a+r/2
dx
a
R
0
(x)e
 
R
x
0
(y)dy
p
+
x,a-r/2
dx
: (18)
Consequently, the survival probabilities depend on the incidence rate, (a), which itself
is a function of values of 
+
. Thus, an iterative estimation procedure must be adopted
choosing initial values for (a) for each age interval. Estimation of the variance of ^(a) is
done by means of the delta method.
Gregson et al. (1996) apply both methods to data comprising 3600 pregnant women
in Uganda who were tested for HIV between 1989 and 1990 in several hospitals of the
capital, Kampala. Incidence estimation is done for age intervals of three years' length.
This implies that the discrete equivalents for the equations given above are used. Similar
values for ^(a) are obtained in both cases. The shape of the age-specic distribution is
smoother in case of the cumulative incidence and survival method resulting from the more
complete use of empirical data, on one hand, and the mathematical function assumed, on
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the other. When applying the constant prevalence method, empirical data of only one
age interval are used for the estimation of (a).
2.4 Compartment Model of Keiding
Another approach to the estimation of incidence of a disease from prevalence data is
presented by Keiding (1991). Keiding uses a compartment model composed of three
states, `healthy', `ill', and `dead', and the corresponding transition rates ; , and . The
disease is assumed to be chronic. The incidence rate, , corresponds to the intensity of the
transition from `healthy' to `ill', whereas  and  denote the transition intensities from
`healthy' to `dead' and `ill' to `dead', respectively.
Keiding describes these transitions with respect to dependence on age, time and du-
ration of disease, considering dierent situations. One of these situations is the case of
time independence in which information about the onset of the disease is not given. This
situation corresponds to the reality of many seroprevalence studies in many countries in
Africa and Asia where the actual date of infection by HIV is usually unknown.
The compartment model makes the following assumptions: births follow a Poisson
process with parameter ; life histories of the individuals are independent of each other;
and life histories are independent of the birth process. Consequently, the process of falling
ill follows a Poisson process with age dependent intensity as follows (Brillinger [1986]):
(a) =  exp
0
@
 
a
Z
0
((u) + (u))du
1
A
(a): (19)
Further, the joint probability density for an individual to fall ill at age y and survive until
age a, a > y, is given by:
h(y, a) = exp
0
@
 
y
Z
0
((u) + (u)) du
1
A
(y) exp
0
B
@
 
a
Z
y
(u)du
1
C
A
: (20)
Thus, the expectation value, E(P
N
; a, y), of the number of individuals with age [a, a+a]
after falling ill at age [y, y+y] is:
E(P
N
; a, y) =  h(y, a) y a: (21)
The net life time probability of falling ill becomes:
R =
1
Z
0
exp
0
@
 
y
Z
0
((u) + (u)) du
1
A
(y)dy: (22)
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Let  = E(A  YjA>Y) be the conditional expectation value of duration of disease given
that the individual has fallen ill. Then equation (2) of subsection 2.1 corresponds to:

1
Z
0
1
Z
y
h(y, a)da dy =  R : (23)
In order to estimate the age-specic incidence rate, nonparametric methods of survival
analysis are used. For example, let G(a) represent the gross probability of contracting the
disease before age a. That is:
G(a) = 1  exp
0
@
a
Z
0
(u)du
1
A
=
a
Z
0
(u)e
 
R
u
0
(s)ds
du: (24)
Thus, the likelihood function depending on  and  in case of equal mortality of aected
and unaected individuals has the following form:
L(; ) = L( )L() = M
 n
n
Y
i=1
exp
0
@
 
a
i
Z
0
(u)du
1
A
n
Y
i=1
(1 G(a
i
))
1 
i
G(a
i
)

i
; (25)
where M denotes the expected life time, 
i
the indicator function, whether an individual
is sick or not, and a
i
the age of individual i.
Maximizing the likelihood function gives a left-continuous estimator of G(a), G(a-),
through which (a) can be estimated (Keiding [1991]). Using a kernel, K, with bandwidth
b prevents the subdivision in several age intervals:
^(a) =
1
b
Z
K

a u
b

d
^
G(u)
1 
^
G(u )
: (26)
Keiding presents an application of this method for data on the incidence rate of Hepatitis
A in Bulgaria.
In case of dierent mortality for aected and unaected individuals, the estimation
procedure for ^(a) remains the same for the following assumptions: mortality of both
aected and unaected is known; the dierence in mortality of aected and unaected is
small; and the disease of interest is rare. However, regarding the HIV-epidemic in many
parts of Africa and Asia these assumptions are hardly fullled, especially in Subsaharan
Africa and in Southeast Asia.
Brunet and Struchiner (1996) have similarly developed a compartment model in which
they consider two groups with the same states, one group receiving a vaccine and the
other group no vaccine. Transition intensities are modeled based on dependence on age
and time and eects of a new treatment or vaccine could then be examined. However,
serial prevalence studies are required to estimate transition rates depending on time.
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3 Discussion
Cohort and serial seroprevalence studies such as those conducted in Ruanda (Bucyendore
et al. [1993]) and Burundi (Saidel et al. [1996]), are still the exception in many parts of
Africa. Usually, single seroprevalence studies are conducted for the estimation of HIV-
incidence. This implies that conclusions about the dynamics of the spread of the HIV-
epidemic can only be drawn from data which reect the situation at one single moment.
Brookmeyer and Gail (1994; Chap. 3) and Brundage et al. (1990) discuss general
problems of seroprevalence studies with emphasis on potential sources of bias. Possible
sources include tests for HIV with low sensitivity or specity, which might be a big problem
where there is low HIV-incidence.
3.1 Practical Considerations of the Methods
Most of the methods discussed in Section 2 could be used to estimate HIV-incidence.
However, the methods by Leske et al. (1981) and Keiding (1991) for the case of equal
mortality of aected and unaected individuals do not seem to be appropriate due to the
high mortality of AIDS.
Due to the fact that the approach of Freeman and Hutchison (1980) does not model
incidence as a function of age, it is not appropriate for the case of infection with HIV.
However, the main equation, `Prevalence = Incidence  Duration of Disease', can be
applied for dierent age intervals. For this, the average life expectancy with HIV would
be necessary to be available for each age interval. A constant number of aected and
unaected individuals over time is required since it is normally not given at the beginning
of an epidemic. A generalization of this method for the case of exponentially growing
populations is presented by Alho (1992).
Brookmeyer and Quinn (1995) refer to several sources of estimation bias in their study
about the HIV-incidence in India using the equation of Freeman and Hutchison (1980).
The main source of uncertainty is the estimation of the duration of the p24 antigen period.
Due to these uncertainties the method seems to be unsuitable in connection with the HIV-
epidemic. Large sample sizes would be required to estimate the expectation value of the
duration of the p24 antigen period with low variance, especially if dependence on age was
modeled. In the context of another study, Brookmeyer et al. (1995) combine the method
of Freeman and Hutchison (1980) with the simple estimator for cumulative incidence in
case of cohort studies. The purpose is to eliminate the main sources of uncertainty in
both methods.
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In connection with several seroprevalence studies in Burundi, Saidel et al. (1996)
compare the incidence estimations with the use of the method of Podgor and Leske (1986)
and with methods which utilize the prevalence values of these studies. They report that
incidence estimation coincides for the chosen age intervals. This indicates that the method
of Podgor and Leske is quite exact. This result is restricted to situations in which the HIV-
epidemic has reached a stable level. As in other methods, the more stable an epidemic is,
the more exact are the incidence estimations.
In contrast with Saidel et al. (1996), Ades and Nokes (1993) show that incidence
estimations are biased when dependence on time is not modeled. They present results
of a study about the spreading of Toxoplasmose in South Yorkshire, England. In order
to model separately dependence on age and on time, data are required for at least two
moments, unless additional information is given, for example, with regard to date of infec-
tion. In many parts of Asia and Africa where HIV is mainly transmitted via heterosexual
relations, this information is normally not available. Thus, a steady-state population
veriable by studies over time must be assumed.
The constant prevalence method of Gregson et al. (1996) is similar to the method
of Leske et al. (1981). However, unlike the latter, negative values for the estimation of
the incidence rate are possible. It should be noted that both methods require constant
age-specic incidence over time. Comparing the constant prevalence method with the
cumulative incidence and survival method, the condition of constant age-specic incidence
over time is more restrictive for the latter. This is because the estimation of the incidence
density for the age interval k requires prevalence estimates of all previous age intervals.
In case of the constant prevalence method, only the prevalence estimate of the previous
age interval is needed. This leads to less variation for the incidence estimates when the
cumulative incidence and survival method is used. Less variation using the cumulative
incidence and survival method is also due to the specication of the incidence density
depending on the age of the individual. In this case therefore, estimation accuracy depends
on the specication of the incidence rate.
The accuracy of the nonparametric method of survival analysis, as presented by Kei-
ding (1991), depends on whether the assumption that births follow a Poisson process
is justied. Besides, the chosen kernel estimate determines the form of the age specic
incidence rate.
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3.2 Future Possibilities
A comparison of the methods as presented above is needed to determine which method is
the most appropriate one in a given situation. This comparison could be done theoretically
by examining the expectation values and variances of the dierent estimators and in a
practical way using simulations or real data. See for example Saidel et al. (1996).
In addition, it is necessary to obtain more information about the population while
conducting seroprevalence studies. Gregson et al. (1996) suggest that a statistical survey
of the potential migration within the population should be made since the assumed steady-
state population could be aected by migration. Regarding epidemics caused by parasites,
de Vlas et al. (1993) model disease incidence in dependence on the amount of parasites in
the blood of the individual. If the possibility exists to obtain the virusload while testing
for HIV, the method of de Vlas et al. might be adaptable to the HIV-epidemic.
By means of the virusload, conclusions about the time of infection could be drawn.
Consequently, the second step could be a more exact estimation of the present incidence
rate. A similar model for the estimation of the number of AIDS cases, as used by the
World Health Organization, is presented by Chin and Lwanga (1991). The backward
calculation method used by the WHO can be used even when the virusload is unknown
since it is the incubation period distribution that is to be modeled.
Furthermore, Bayesian methods could be developed in order to utilize any prior infor-
mation about the incidence rate. This might allow for more accurate estimations.
Finally, further investigations could be focused on the geographical spread of the HIV-
epidemic using methods of spatial statistics. Especially in countries having one big urban
centre, the capital, with surrounding rural provinces, there might be a big dierence
between the spread of HIV-infection in urban and rural communities. On the other hand,
due to migration from and to the urban centre, the dynamic of the spread of HIV in urban
and rural areas will be interrelated. Examining the spatial spread of the epidemic over
time might aid the planning of ecient HIV-prevention campaigns in the future.
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